Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 30, 2024 10:45 ET | Source: Research and Markets

Regorafenib Drug and Market Analysis 2023-2032 with Forecasted Sales Data

Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Regorafenib Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report offers a comprehensive...
May 04, 2023 07:28 ET | Source: Research and Markets

Colorectal Cancer Diagnostics Market Research Report 2023: Rising Consumer Acceptance of Advanced Therapies Such as Stivarga (regorafenib), Erbitux (cetuximab), & Avastin (bevacizumab) Bolsters Growth

Dublin, May 04, 2023 (GLOBE NEWSWIRE) -- The "Colorectal Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Diagnosis Type, By...
January 16, 2019 13:56 ET | Source: National Brain Tumor Society

National Brain Tumor Society Invests in GBM AGILE, the World’s First Global Adaptive Trial for Glioblastoma Brain Cancer

Boston, MA, Jan. 16, 2019 (GLOBE NEWSWIRE) -- National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, today announced a partnership...